Rigel Pharmaceuticals Inc

Ownership Transactions Reported by 17 Insiders

Symbol
RIGL on Nasdaq
Location
611 Gateway Boulevard, Suite 900, South San Francisco, CA

Insiders trading volume in the past year

Rigel Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Raul R. Rodriguez CEO, President, Director $5.25M -$200K -3.67% Sep 15, 2025
Dean L. Schorno EVP & Chief Financial Officer $1.25M -$80.6K -6.04% Sep 15, 2025
David A. Santos EVP, Chief Commercial Officer $1.13M -$83.8K -6.89% Sep 15, 2025
Raymond Furey EVP, GC, CCO & Corp Sec $851K -$59.7K -6.55% Sep 15, 2025
Lisa Rojkjaer EVP, Chief Medical Officer $437K Sep 15, 2025
Walter H. Moos Director $242K May 23, 2025
Anthony Gregg Lapointe Director $238K May 23, 2025
Jane Wasman Director $238K May 23, 2025
Alison L. Hannah Director $203K May 23, 2025
Kamil Ali-Jackson Director $179K May 23, 2025
Lyons Gary A Director $131K May 26, 2023
Wolfgang Dummer Evp & Cmo $127K Feb 2, 2023
Brian L. Kotzin Director $114K May 25, 2024
Dolly Vance EVP Corp. Affairs, G.C., Sect. $105K Sep 14, 2022
Bradford S. Goodwin Director $61.3K May 19, 2021
Keith Katkin Director $43.8K May 19, 2021
Mark W. Frohlich Director $23.8K May 23, 2025

Recent Insider Transactions by Companies or Individuals for Rigel Pharmaceuticals Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.